HCA Healthcare, Inc. (NYSE:HCA) Shares Bought by Fisher Funds Management LTD

Fisher Funds Management LTD increased its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 18.7% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 85,119 shares of the company's stock after acquiring an additional 13,390 shares during the period. Fisher Funds Management LTD's holdings in HCA Healthcare were worth $29,413,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Congress Wealth Management LLC DE boosted its position in shares of HCA Healthcare by 3.4% during the fourth quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company's stock valued at $312,000 after buying an additional 34 shares during the period. Evergreen Private Wealth LLC boosted its position in shares of HCA Healthcare by 0.3% during the fourth quarter. Evergreen Private Wealth LLC now owns 12,787 shares of the company's stock valued at $3,838,000 after buying an additional 35 shares during the period. Perigon Wealth Management LLC boosted its position in shares of HCA Healthcare by 2.3% during the first quarter. Perigon Wealth Management LLC now owns 1,797 shares of the company's stock valued at $621,000 after buying an additional 40 shares during the period. Whittier Trust Co. boosted its position in shares of HCA Healthcare by 3.6% during the fourth quarter. Whittier Trust Co. now owns 1,195 shares of the company's stock valued at $359,000 after buying an additional 41 shares during the period. Finally, Barden Capital Management Inc. boosted its position in shares of HCA Healthcare by 1.4% during the first quarter. Barden Capital Management Inc. now owns 2,921 shares of the company's stock valued at $1,009,000 after buying an additional 41 shares during the period. Hedge funds and other institutional investors own 62.73% of the company's stock.

HCA Healthcare Stock Performance

Shares of NYSE HCA traded up $1.93 during trading on Monday, reaching $378.51. 1,369,708 shares of the company traded hands, compared to its average volume of 1,463,071. The firm's fifty day simple moving average is $371.55 and its 200 day simple moving average is $339.67. The stock has a market cap of $91.06 billion, a P/E ratio of 16.83, a PEG ratio of 1.30 and a beta of 1.47. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14. The company has a current ratio of 1.19, a quick ratio of 1.06 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, beating analysts' consensus estimates of $5.75 by $0.70. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. The business had revenue of $18.32 billion during the quarter, compared to analyst estimates of $18.26 billion. During the same quarter last year, the business posted $5.36 EPS. The company's revenue was up 5.7% on a year-over-year basis. As a group, research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, June 30th. Stockholders of record on Monday, June 16th were given a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.76%. The ex-dividend date was Monday, June 16th. HCA Healthcare's dividend payout ratio (DPR) is presently 12.81%.

Insider Transactions at HCA Healthcare

In related news, COO Jon M. Foster sold 15,698 shares of HCA Healthcare stock in a transaction dated Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total value of $5,797,585.36. Following the sale, the chief operating officer directly owned 12,646 shares in the company, valued at approximately $4,670,420.72. The trade was a 55.38% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders own 1.30% of the company's stock.

Wall Street Analyst Weigh In

HCA has been the subject of several research analyst reports. Morgan Stanley set a $410.00 price target on shares of HCA Healthcare and gave the company an "equal weight" rating in a research note on Monday, June 9th. Royal Bank Of Canada reaffirmed an "outperform" rating and set a $404.00 target price (up previously from $376.00) on shares of HCA Healthcare in a research report on Monday, June 23rd. Baird R W cut HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Robert W. Baird reaffirmed a "neutral" rating and set a $336.00 target price (down previously from $396.00) on shares of HCA Healthcare in a research report on Tuesday, April 15th. Finally, Stephens raised HCA Healthcare to a "strong-buy" rating in a research report on Monday, June 2nd. Seven analysts have rated the stock with a hold rating, eleven have assigned a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $395.71.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.